
Raloxifene
CAS No. 84449-90-1
Raloxifene( Pharoxifene | Raloxifenum | Keoxifene | LY-139481 )
Catalog No. M24833 CAS No. 84449-90-1
Raloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 48 | In Stock |
![]() ![]() |
5MG | 70 | In Stock |
![]() ![]() |
10MG | 116 | In Stock |
![]() ![]() |
25MG | 216 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameRaloxifene
-
NoteResearch use only, not for human use.
-
Brief DescriptionRaloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
-
DescriptionRaloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
-
In Vitro——
-
In VivoRaloxifene (4?mg/kg; intragastrically; daily for 13 weeks) significantly prevents bone loss in ovariectomized (OVX) rats. Animal Model:Female, 12-week-old, Wistar rats (OVX rats) Dosage:4?mg/kg Administration:Intragastrically; daily for 13 weeks Result:Significantly increased the levels of E2 in OVX rats and significantly decreased the levels of BGP.
-
SynonymsPharoxifene | Raloxifenum | Keoxifene | LY-139481
-
PathwayOthers
-
TargetOther Targets
-
RecptorSERM
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84449-90-1
-
Formula Weight473.58
-
Molecular FormulaC28H27NO4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:90 mg/mL (190.04 mM; Need ultrasonic);Ethanol:9 mg/mL (19.00 mM; Need ultrasonic)
-
SMILESOc(cc1)ccc1-c1c(C(c(cc2)ccc2OCCN2CCCCC2)=O)c(ccc(O)c2)c2s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Khovidhunkit W, et al. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med. 1999;130(5):431-439.
molnova catalog



related products
-
Doxpicomine
Doxpicomine has analgesic activity and can be used to treat postoperative pain.
-
Alopecurone A
Alopecurone A exhibits potent inhibitory activity on MRP1.
-
IXA4
IXA4 is a highly selective, nontoxic activator of IRE1/XBP1s and reduces APP secretion by activating IRE1. IXA4-stimulated IRE1 activation also enhanced pancreatic function.